Literature DB >> 17002843

Prostate cancer treatment. The case for radical prostatectomy.

Miles A Goldstraw1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17002843      PMCID： PMC1994517          DOI： 10.1308/003588406X117133

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


× No keyword cloud information.
  25 in total

1.  Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma.

Authors:  John W Robinson; Sabine Moritz; Tak Fung
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-15       Impact factor: 7.038

2.  An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up.

Authors:  Frank A Vicini; Alvaro Martinez; Gerald Hanks; Alex Hanlon; Brian Miles; Ken Kernan; David Beyers; Haakon Ragde; Jeffrey Forman; James Fontanesi; Larry Kestin; Gyorgy Kovacs; Louis Denis; Kevin Slawin; Peter Scardino
Journal:  Cancer       Date:  2002-11-15       Impact factor: 6.860

3.  A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution.

Authors:  A A Martinez; J A Gonzalez; A K Chung; L L Kestin; M Balasubramaniam; A C Diokno; E L Ziaja; D S Brabbins; F A Vicini
Journal:  Cancer       Date:  2000-01-15       Impact factor: 6.860

4.  Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone.

Authors:  H Ragde; G L Grado; B S Nadir
Journal:  Arch Esp Urol       Date:  2001-09       Impact factor: 0.436

5.  Potency after permanent prostate brachytherapy for localized prostate cancer.

Authors:  L Potters; T Torre; P A Fearn; S A Leibel; M W Kattan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-08-01       Impact factor: 7.038

6.  Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.

Authors:  H Ragde; L J Korb; A A Elgamal; G L Grado; B S Nadir
Journal:  Cancer       Date:  2000-07-01       Impact factor: 6.860

7.  (125)Iodine prostate brachytherapy: outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics.

Authors:  A Henderson; D Cahill; R W Laing; S E M Langley
Journal:  BJU Int       Date:  2002-10       Impact factor: 5.588

8.  Patient self-reporting questionnaire on urological morbidity and bother after radical retropubic prostatectomy.

Authors:  Herbert Augustin; Karl Pummer; Fedor Daghofer; Helga Habermann; Günter Primus; Gerhart Hubmer
Journal:  Eur Urol       Date:  2002-08       Impact factor: 20.096

9.  Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.

Authors:  Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Kerri Cote; Marian Loffredo; Delray Schultz; Ming-Hui Chen; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

10.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.